Diagnostic and Prognostic utility of eNOSE for Lung Cancer in a TB-endemic setting: A Pilot Study

R. Vadala (New Delhii, India), B. Pattnaik (New Delhii, India), N. Bhatraju (New Delhii, India), D. Rai (New Delhii, India), J. Tak (New Delhii, India), S. Kashyap (New Delhii, India), U. Verma (New Delhii, India), G. Yadav (New Delhii, India), R. Dhaliwal (New Delhii, India), R. Guleria (New Delhii, India), A. Agrawal (New Delhii, India), A. Mohan (New Delhii, India)

Source: International Congress 2022 – Bridging lung cancer screening with early diagnostics

Session: Bridging lung cancer screening with early diagnostics
Session type: Thematic Poster
Number: 3413

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Vadala (New Delhii, India), B. Pattnaik (New Delhii, India), N. Bhatraju (New Delhii, India), D. Rai (New Delhii, India), J. Tak (New Delhii, India), S. Kashyap (New Delhii, India), U. Verma (New Delhii, India), G. Yadav (New Delhii, India), R. Dhaliwal (New Delhii, India), R. Guleria (New Delhii, India), A. Agrawal (New Delhii, India), A. Mohan (New Delhii, India). Diagnostic and Prognostic utility of eNOSE for Lung Cancer in a TB-endemic setting: A Pilot Study. 3413

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.